Cambridge, MA, April 18, 2013 - It is rare that an unpublished piece of research or theory remains significant after half a century. It is also a wonderful example of the boundless curiosity of the late Francis Crick. A previously unpublished work by Francis Crick and Jeffries Wyman from 1965 is now available, together with Jean-Pierre Changeux's recollections on the origins of the theory of Allostery and several important texts by various authors on the subject. These are part of a special issue of the Journal of Molecular Biology (JMB) published at the occasion of a Pasteur/EMBO Conference on Allosteric Interactions in Cell Signaling and Regulation to be held at the Pasteur Institute in Paris, May 14-17, 2013, to mark a half-century of research on this subject.
Early in 1963 an influential theory was published by Jacques Monod, Jean-Pierre Changeux and François Jacob in JMB to explain how binding of a regulatory molecule could influence the binding of a completely different kind of molecule at topographically distinct sites. The word allosteric was invented, based on the Greek allos "other", and stereos "solid (object)" and a conformational change postulated to account for the interaction between sites. The theory was further extended in 1965 by Monod, Wyman and Changeux in a classical paper dealing in particular with the important threshold effects that accompany the binding of ligand molecules to regulatory proteins and that they assigned to the cooperative multi-subunit organization of the protein. One issue of the theory related to how the conformational transition involved in the signal transduction process was influenced by the number of sites for each ligand. The Crick-Wyman manuscript proposes a somewhat different formulation of Monod-Wyman-Changeux hypothesis through the critical analysis of how the regulatory performances of a monomeric protein are enhanced by their assembly into a cooperative structure.
An initial version of the manuscript was initially circulated within Jacques Monod's group at the Pasteur Institute, but the text was never submitted for publication. Stuart Edelstein, an Editor of the special issue, arranged posthumous publication and has written a preface to place the text in context.
Francis Crick had a strong impact in several areas of biology, but most scientists will be surprised to discover that he also took a strong interest in allosteric interactions. A major research institute bearing his name is currently under construction in Central London. Sir Paul Nurse, Chief Executive of the new institute and President of the Royal Society commented on publication of the Crick-Wyman text: "As we enter into the final phases of construction of the Francis Crick Institute, it is satisfying to discover yet another feather in Francis Crick's already crowded cap. Few knew that he took a serious interest in allosteric proteins and developed original ideas that after nearly fifty years still remain relevant to current research issues. Bringing this unpublished text to the scientific community is an exciting event to mark the 50th anniversary of allostery."
The conference in May at the Pasteur Institute will include presentations by 40 world-renown scientists, including seven Nobel Prize laureates. The program comprises seven half-day sessions devoted to various subjects for which allosteric interactions play an important role, including enzymes, receptors, chaperones, ribo-switches, and complex molecular machines such as ribosomes, motors and replication complexes.
An exhibition shall be presented at the Pasteur Institute during the conference on the history of allostery and subsequent debates based upon original documents selected by Henri Buc from the Pasteur Institute's archives.
Francis Crick (1916-2004) was awarded the Nobel Prize for Physiology or Medicine in 1962 along with James Watson and Maurice Wilkins for their work in describing the structure of DNA and its significance for information transfer in living things. Jeffries Wyman (1901-1995), a distinguished physical chemist of proteins was a founder and past secretary general of the European Molecular Biology Organization (EMBO). Jean-Pierre Changeux completed his PhD with Jacques Monod on the bacterial regulatory enzyme, l-threonine deaminase, leading to the discovery of "allosteric" sites. He subsequently isolated the nicotinic acetylcholine receptor and demonstrated its allosteric properties. Changeux, a member of the National Academy of Sciences (USA), has received the Wolf and the Balzan prizes, and is currently Honorary Professor at the College de France and the Pasteur Institute.
The articles are "A Footnote on Allostery" by F.H.C. Crick and Jeffries Wyman, and "The origins of allostery: From personal memories to material for the future" by Jean-Pierre Changeux. The articles appear in The Journal of Molecular Biology, Volume 425, Issue 9, pages 1500-1508 and pages 1396-1406, respectively, (May 13, 2013), published by Elsevier.
Notes for Editors
Copies of the articles are available to credentialed journalists upon request; contact Meghan Jendrysik at +1 617 397 2845 or email@example.com. Journalists wishing to interview the editor may contact Stuart Edelstein at Stuart.Edelstein@unige.ch. Jean-Pierre Changeux can be contacted at firstname.lastname@example.org .
Stuart Edelstein, a Foreign Associate of the French Academy of Sciences, is Emeritus Professor of Biochemistry at the University of Geneva, Visiting Scientist at the Babraham Institute (Cambridge, UK), and Scientific Director of the French Biotech magazine BIOFUTUR. He is also a co-organizer of the May conference in Paris on Allosteric Interactions.
Information about the Conference can be found at http://www.
About Journal of Molecular Biology
The Journal of Molecular Biology provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide functional and mechanistic insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions. http://www.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).